These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 27852323)
1. Circulating exosomes from patients with systemic lupus erythematosus induce an proinflammatory immune response. Lee JY; Park JK; Lee EY; Lee EB; Song YW Arthritis Res Ther; 2016 Nov; 18(1):264. PubMed ID: 27852323 [TBL] [Abstract][Full Text] [Related]
2. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus. Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093 [TBL] [Abstract][Full Text] [Related]
3. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus. Sakata K; Nakayamada S; Miyazaki Y; Kubo S; Ishii A; Nakano K; Tanaka Y Front Immunol; 2018; 9():1957. PubMed ID: 30210502 [No Abstract] [Full Text] [Related]
4. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. Ye L; Ji L; Wen Z; Zhou Y; Hu D; Li Y; Yu T; Chen B; Zhang J; Ding L; Du J; Huang Z J Transl Med; 2014 Mar; 12():69. PubMed ID: 24629023 [TBL] [Abstract][Full Text] [Related]
5. Altered IL-10 and TNF-α production in peripheral blood mononuclear cells of systemic lupus erythematosus patients after Toll-like receptor 2, 4, or 9 activation. Tsao JT; Hsieh SC; Chiang BL; Yu CL; Lin SC Clin Exp Med; 2012 Sep; 12(3):153-8. PubMed ID: 22057691 [TBL] [Abstract][Full Text] [Related]
6. Pro-Inflammatory Cytokines are Elevated in Pregnant Women with Systemic Lupus Erythematosus in Association with the Activation of TLR4. Qu X; Yu X; Liu J; Wang J; Liu J Clin Lab; 2016; 62(4):535-44. PubMed ID: 27215071 [TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus. Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926 [TBL] [Abstract][Full Text] [Related]
8. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective? Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of plasma levels and immunoactivities of different forms of circulating-free DNA in systemic lupus erythematosus patients]. Huang J; Li Z; Cheng L; Zhang P; Li X; Feng G Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jul; 37(7):633-640. PubMed ID: 34140075 [TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Sabry A; Sheashaa H; El-Husseini A; Mahmoud K; Eldahshan KF; George SK; Abdel-Khalek E; El-Shafey EM; Abo-Zenah H Cytokine; 2006 Aug; 35(3-4):148-53. PubMed ID: 17027280 [TBL] [Abstract][Full Text] [Related]
12. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients. Mortezagholi S; Babaloo Z; Rahimzadeh P; Namdari H; Ghaedi M; Gharibdoost F; Mirzaei R; Bidad K; Salehi E Immunopharmacol Immunotoxicol; 2017 Feb; 39(1):11-18. PubMed ID: 28049380 [TBL] [Abstract][Full Text] [Related]
14. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus. Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production. Li Y; Wang R; Liu S; Liu J; Pan W; Li F; Li J; Meng D Int Immunopharmacol; 2019 Sep; 74():105680. PubMed ID: 31200339 [TBL] [Abstract][Full Text] [Related]
16. IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE). Oke V; Brauner S; Larsson A; Gustafsson J; Zickert A; Gunnarsson I; Svenungsson E Arthritis Res Ther; 2017 Jun; 19(1):139. PubMed ID: 28619037 [TBL] [Abstract][Full Text] [Related]
17. CD47 Potentiates Inflammatory Response in Systemic Lupus Erythematosus. Park JK; Lee YJ; Park JS; Lee EB; Song YW Cells; 2021 May; 10(5):. PubMed ID: 34068752 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs. Lyn-Cook BD; Xie C; Oates J; Treadwell E; Word B; Hammons G; Wiley K Mol Immunol; 2014 Sep; 61(1):38-43. PubMed ID: 24865418 [TBL] [Abstract][Full Text] [Related]
19. Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus. Mende R; Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Lin E; Chang J; Hoi AY; Morand EF; Harris J; Lang T Front Immunol; 2018; 9():1250. PubMed ID: 29930551 [TBL] [Abstract][Full Text] [Related]
20. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus. Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]